Keros Therapeutics, Inc. (KROS)

Last Year

15-May-23 -- 14-May-24

Time Period:
0 Net Amount
Buy:0--
Sell:0--

Company Sentiment

Other

Other

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
0
(1)
10
0
0
+1
0
+2
0
+3

Two Year Chart

15-May-22 -- 14-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
08-Jan-24 4:43 PM
View: 		04-Nov-23
Planned Option Sale
($1.81M)
Regnante Keith
Chief Financial Officer
Insider Trading Sentiment for Regnante Keith at Keros Therapeutics, Inc. (KROS):Keros Therapeutics, Inc. - KROS0%
--		0
0
---- Show TxnsShow Insider Trades